Commentary: Esophageal cancer —a story for the ages?

The last 3  decades have seen progress in the treatment of esophageal cancer, with a reduction in mortality rates for esophagectomy at high-volume specialty centers. We have seen advances in our understanding of the potential advantages of neoadjuvant and adjuvant therapies and progress in our ability to perf orm minimally invasive esophagectomy.1 There is promise that we will witness success with immunotherapies to further improve the outlook for treating this high-mortality cancer. However, while we make progress after the diagnosis is made, appropriate screening and diagnosing guidelines for endoscopy in patients with symptoms that are worrisome for esophageal adenocarcinoma have lagged.
Source: The Journal of Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: Commentary Source Type: research